$2.33T
Total marketcap
$97.35B
Total volume
BTC 50.06%     ETH 15.40%
Dominance

NexgenRx Inc. NXG.V Stock

0.24 CAD {{ price }} 6.818182% {{change_pct}}%
COUNTRY
Canada
Exchange
TSXV
Market Cap
16.57M CAD
LOW - HIGH [24H]
0.24 - 0.24 CAD
VOLUME [24H]
1K CAD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.01 CAD

NexgenRx Inc. Price Chart

NexgenRx Inc. NXG.V Financial and Trading Overview

NexgenRx Inc. stock price 0.24 CAD
Previous Close 0.32 CAD
Open 0.32 CAD
Bid 0.29 CAD x 0
Ask 0.32 CAD x 0
Day's Range 0.32 - 0.32 CAD
52 Week Range 0.24 - 0.39 CAD
Volume 500 CAD
Avg. Volume 1.97K CAD
Market Cap 22.51M CAD
Beta (5Y Monthly) 0.311688
PE Ratio (TTM) N/A
EPS (TTM) -0.01 CAD
Forward Dividend & Yield 0.02 (6.25%)
Ex-Dividend Date September 29, 2022
1y Target Est 4.25 CAD

NXG.V Valuation Measures

Enterprise Value 23.31M CAD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.7226036
Price/Book (mrq) 3.047619
Enterprise Value/Revenue 1.784
Enterprise Value/EBITDA 18.003

Trading Information

NexgenRx Inc. Stock Price History

Beta (5Y Monthly) 0.311688
52-Week Change 0%
S&P500 52-Week Change 20.43%
52 Week High 0.39 CAD
52 Week Low 0.24 CAD
50-Day Moving Average 0.32 CAD
200-Day Moving Average 0.31 CAD

NXG.V Share Statistics

Avg. Volume (3 month) 1.97K CAD
Avg. Daily Volume (10-Days) 300 CAD
Shares Outstanding 70.34M
Float 43.91M
Short Ratio 0.01
% Held by Insiders 36.93%
% Held by Institutions 0%
Shares Short 87
Short % of Float N/A
Short % of Shares Outstanding 0%

Dividends & Splits

Trailing Annual Dividend Rate 0.005
Trailing Annual Dividend Yield 1.56%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -1.57%
Operating Margin (ttm) 0.80%
Gross Margin 78.95%
EBITDA Margin 9.91%

Management Effectiveness

Return on Assets (ttm) 0.21%
Return on Equity (ttm) -2.19%

Income Statement

Revenue (ttm) 13.07M CAD
Revenue Per Share (ttm) 0.19 CAD
Quarterly Revenue Growth (yoy) 9.00%
Gross Profit (ttm) N/A
EBITDA 1.3M CAD
Net Income Avi to Common (ttm) -172430 CAD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) -48.39%

Balance Sheet

Total Cash (mrq) 1.26M CAD
Total Cash Per Share (mrq) 0.02 CAD
Total Debt (mrq) 421.55K CAD
Total Debt/Equity (mrq) 4.67 CAD
Current Ratio (mrq) 1.103
Book Value Per Share (mrq) 0.105

Cash Flow Statement

Operating Cash Flow (ttm) 998.53K CAD
Levered Free Cash Flow (ttm) 571.25K CAD

Profile of NexgenRx Inc.

Country Canada
State ON
City Toronto
Address 191 The West Mall
ZIP M9C 5L6
Phone 416-695-3393
Website https://www.nexgenrx.com
Industry Healthcare Plans
Sector(s) Healthcare
Full Time Employees N/A

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

Q&A For NexgenRx Inc. Stock

What is a current NXG.V stock price?

NexgenRx Inc. NXG.V stock price today per share is 0.24 CAD.

How to purchase NexgenRx Inc. stock?

You can buy NXG.V shares on the TSXV exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for NexgenRx Inc.?

The stock symbol or ticker of NexgenRx Inc. is NXG.V.

Which industry does the NexgenRx Inc. company belong to?

The NexgenRx Inc. industry is Healthcare Plans.

How many shares does NexgenRx Inc. have in circulation?

The max supply of NexgenRx Inc. shares is 70.53M.

What is NexgenRx Inc. Price to Earnings Ratio (PE Ratio)?

NexgenRx Inc. PE Ratio is now.

What was NexgenRx Inc. earnings per share over the trailing 12 months (TTM)?

NexgenRx Inc. EPS is -0.01 CAD over the trailing 12 months.

Which sector does the NexgenRx Inc. company belong to?

The NexgenRx Inc. sector is Healthcare.